{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765946",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765946_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"captopril\" outputclass=\"int-drug\">Captopril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypersensitivity when given with</ph> <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">sodium aurothiomalate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Captopril   is predicted to   increase   the risk of hypersensitivity when given with   sodium aurothiomalate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Captopril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765947",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765947_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"enalapril\" outputclass=\"int-drug\">Enalapril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypersensitivity when given with</ph> <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">sodium aurothiomalate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Enalapril   is predicted to   increase   the risk of hypersensitivity when given with   sodium aurothiomalate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Enalapril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765948",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765948_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fosinopril\" outputclass=\"int-drug\">Fosinopril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypersensitivity when given with</ph> <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">sodium aurothiomalate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fosinopril   is predicted to   increase   the risk of hypersensitivity when given with   sodium aurothiomalate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fosinopril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765949",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765949_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"imidapril\" outputclass=\"int-drug\">Imidapril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypersensitivity when given with</ph> <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">sodium aurothiomalate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Imidapril   is predicted to   increase   the risk of hypersensitivity when given with   sodium aurothiomalate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Imidapril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765950",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765950_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"lisinopril\" outputclass=\"int-drug\">Lisinopril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypersensitivity when given with</ph> <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">sodium aurothiomalate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Lisinopril   is predicted to   increase   the risk of hypersensitivity when given with   sodium aurothiomalate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lisinopril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765951",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765951_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">Sodium aurothiomalate</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of side-effects when given with</ph> <ph otherprops=\"penicillamine\" outputclass=\"int-drug\">penicillamine</ph> <ph outputclass=\"int-substanceQualifier\">(in those who have had previous adverse reactions to gold)</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Sodium aurothiomalate   potentially   increases   the risk of side-effects when given with   penicillamine   (in those who have had previous adverse reactions to gold) .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Penicillamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765952",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765952_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"perindopril\" outputclass=\"int-drug\">Perindopril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypersensitivity when given with</ph> <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">sodium aurothiomalate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Perindopril   is predicted to   increase   the risk of hypersensitivity when given with   sodium aurothiomalate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Perindopril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765953",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765953_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"quinapril\" outputclass=\"int-drug\">Quinapril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypersensitivity when given with</ph> <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">sodium aurothiomalate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Quinapril   is predicted to   increase   the risk of hypersensitivity when given with   sodium aurothiomalate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Quinapril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765954",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765954_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ramipril\" outputclass=\"int-drug\">Ramipril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypersensitivity when given with</ph> <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">sodium aurothiomalate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ramipril   is predicted to   increase   the risk of hypersensitivity when given with   sodium aurothiomalate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ramipril</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765955",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2#bnf_i1557280765955_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"trandolapril\" outputclass=\"int-drug\">Trandolapril</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of hypersensitivity when given with</ph> <ph otherprops=\"sodium aurothiomalate\" outputclass=\"int-heading-drug\">sodium aurothiomalate</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Trandolapril   is predicted to   increase   the risk of hypersensitivity when given with   sodium aurothiomalate .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Trandolapril</title>"
					}
				}
			],
			"hasSearchLabel": " Sodium aurothiomalate  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/sodium-aurothiomalate-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Sodium aurothiomalate </title>"
			},
			"rdfs:label": "sodium aurothiomalate"
		}
	]
}